Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The New Serum-Free OptiPASS® Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids.
Cancers (Basel). 2021 Apr 18;13(8):1945. doi: 10.3390/cancers13081945.
Cancers (Basel). 2021.
PMID: 33919619
Free PMC article.
LightSpot®-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models.
Goisnard A, Daumar P, Dubois C, Aubel C, Roux M, Depresle M, Gauthier J, Vidalinc B, Penault-Llorca F, Mounetou E, Bamdad M.
Goisnard A, et al. Among authors: vidalinc b.
Cancers (Basel). 2021 Aug 11;13(16):4050. doi: 10.3390/cancers13164050.
Cancers (Basel). 2021.
PMID: 34439204
Free PMC article.
Item in Clipboard
The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.
Dubois C, Daumar P, Aubel C, Gauthier J, Vidalinc B, Mounetou E, Penault-Llorca F, Bamdad M.
Dubois C, et al. Among authors: vidalinc b.
J Clin Med. 2019 Mar 21;8(3):397. doi: 10.3390/jcm8030397.
J Clin Med. 2019.
PMID: 30901969
Free PMC article.
Item in Clipboard
Cite
Cite